| CBCS In The News | | Very Scary People-Richard Kuklinski
Headline News-U.S. Cable
in the hope that the time of death would be not known. >> later, we were able to establish that mr. masgay had been taken to a garage in north bergen, new jersey. Why Is My Face Changing Shape As I Get Older?
Gizmodo Australia
Ross Andel Professor, School of Ageing Studies, University of South Florida Christopher B. Forrest Professor and Chair, Plastic... | | | New Publications | - Chandregowda, A., Duffy, J. R., Machulda, M. M., Lowe, V. J., Whitwell, J. L., & Josephs, K. A. (2021). Neurodegeneration of the visual word form area in a patient with word form alexia. Neurology and Clinical Neuroscience. doi: 10.1111/ncn3.12516
- Umucu, E., Reyes, A., Ürkmez, B., Ergun, G., Rios, Y. C., & Kosyluk, K. (2021). Development and Validation of a Scale of Negative Attitudes Toward COVID-19 With a Sample of People With Chronic Conditions and Disabilities. Journal of Applied Rehabilitation Counseling, 52(2), 61–72. doi: 10.1891/jarc-d-20-00042
| | | | CBCS Doctoral Dissertation Defenses | Title: Multidimensional Well-Being Across Time Scales in Caregivers and Non-Caregivers
Student: Victoria R. Marino, BA
Program: Aging Studies
Date: Friday, June 11, 2021
Time: 1:00pm
Location: Microsoft Teams
Title: Development and Testing of the Performance Diagnostic Checklist for Instructors
Student: Jesse DePaolo
Department: ABA
Date: Monday, June 21, 2021
Time: 10:00am
Location: Microsoft Teams | | | | | |
School of Social Work doctoral student, Stephanie Rosado, has been asked to be a panelist for a drug development workshop co-sponsored by the FDA and the Arthritis Foundation. This is a one-day virtual osteoarthritis drug development workshop, set to convene on June 22nd, 2021. The workshop objectives are to provide forum for open discussion between osteoarthritis experts in academia, industry, non-profit sector, patients, and government with the hope of expediting the development of safe and effective treatments for osteoarthritis. Some key objectives are to identify study designs and clinically meaningful clinical trial endpoints that can be used to demonstrate long-term clinical benefit to patients with osteoarthritis and discuss the role of biomarkers in drug development for the disease. Stephanie will be a panelist for the Q&A session in "Assessment of OA Disease and Progression and Long-term Benefit". 